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Summary Chemical structures of the sugar chains of various human ax-fetoprotein (AFP) species with
different affinity for Concanavalin A (Con A) and Lens culinaris agglutinin (LCA) were examined by
pyridylamination of their oligosaccharides and stepwise exoglycosidase digestion. Using reversed-phase and
size-fractionation high performance liquid chromatography systems we identified six pyridylamino-sugar
chains. The Con A-reactive and LCA-nonreactive species of AFP from patients with hepatocellular carcinoma
contained a biantennary sugar chain, and the Con A-reactive and LCA-reactive species had a biantennary one
with a fucose residue at the innermost N-acetylglucosamine residue. The Con A-nonreactive and LCA-reactive
species contained a biantennary sugar chain both with a bisecting-N-acetylglucosamine residue at the triman-
nosyl core and with a focuse residue at the innermost N-acetylglucosamine residue. The Con A-nonreactive
and LCA-nonreactive species contained a fucosylated triantennary sugar chain as a major component, and two
minor components: a triantennary sugar chain and a biantennary sugar chain with a bisecting-N-acetyl-
glucosamine residue at the trimannosyl core. Thus, the fucosylated and non-fucosylated triantennary sugar
chains were newly identified in human AFP. Essentially identical results were obtained for AFP from the
patient with gallbladder carcinoma which metastasises to the liver. These results indicate that the increment in
fucosylation and branching to form new antennae is a characteristic feature of the carbohydrate chains of
AFP from patients with neoplastic diseases of the liver.
The measurement of the serum concentration ofa-fetoprotein
(AFP) has been used extensively for the early diagnosis of
hepatocellular carcinoma (HCC) during a follow-up process
of chronic liver diseases (Abelev, 1986; O'Conor et al., 1970;
Nishi & Hirai, 1973). However, the serum concentration of
AFP also increases in patients with carcinomas of digestive
organs which metastasise to the liver (Alpert et al., 1971;
Mcintire et al., 1975) and with nonneoplastic diseases of the
liver (Karvountzis & Redeker, 1974; Alpert & Feller, 1978).
Several investigators and we have reported that the reac-
tivity of AFP with Lens culinaris agglutinin (LCA) and con-
canavalin A (Con A) is a good measure for distinction
between HCC, nonneoplastic diseases of the liver and car-
cinomas of digestive organs which metastasise to the liver
(Ruoslahti et al., 1978; Breborowicz et al., 1981; Ishiguro et
al., 1985; Taketa & Hirai, 1989; Aoyagi et al., 1984, 1991).
The molecular basis for the different affinity ofAFP for LCA
and Con A is presumed to be the difference in fucosylation at
the innermost N-acetylglucosamine residue and bisecting-
Correspondence: Y. Aoyagi.
In this paper, the terms of sugar chains are used for those with
structures as follows. Biantennary, Galp1-4GlcNAcp1-2 Manal-6
(Galpl-4Glc NAcp1-2 Manal-3) Manp1-4 GlcNAcp1-4 GlcNAc-
PA; agalactobiantennary, GlcNAcp1-2 Manml-6) GlcNAcpl-2 Mana
1-3) Manp1-4 GlcNAc,1-4 GlcNAc-PA; trimannosyl, Manal-6
(Manal-3) Manpl-4 GlcNAcp1-4 GlcNAc-PA; fucosylated bianten-
nary, Galpl-4 GlcNAcpl-2 Manal-6 (Galp1-4 GlcNAcp1-2 Manal-
3) Manpl-4 GlcNAcpl-4 (Fucal-6) GlcNAc-PA; fucosylated and
N-acetylglucosaminylated biantennary, Galp1-4 GlcNAcp1-2 Manal-
6 (GlcNAcp1-4) (Galpl-4 GlcNAcpI-2 Manal-3) Manp1-4 Glc
NAcp1-4 (Fuca1-6) GIcNAc-PA; N-acetylglucosaminylated bianten-
nary, Galp1-4 GlcNAcpl-2 Manal-6 (GlcNAcpl-4) (Galpl-4
GlcNAcp1-2 Manal-3) Manpl-4 GlcNAcpl-4 GlcNAc-PA; fucosy-
lated triantennary, Galp1-4 GlcNAcpl-4 (Galp1-4 GlcNAcp1-2)
Manal-3 (Galp1-4 GlcNAcp1-2 Manal-6) Manp1-4 GlcNAcp1-4
(Fucal-6) GlcNAc-PA; triantennary, Galp1-4 GlcNAcp1-4 (Galp1-4
GlcNAcp1-2) Manxl-3 (Galipl-4 GIcNAcp1-2 Manxl-6) Manpl-4 GIcNAcpI-4 GlcNAc-PA; agalactotriantennary, GlcNAcp1-4 (Glc
NAcp1-2) Manal-3 (GlcNAcp1-2 Manxl-6) Manpl-4 GlcNAcpl-4
GlcNAc-PA.
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glucosaminylation in the biantennary carbohydrate chain
(Aoyagi et al., 1985). However, precise chemical structures of
sugar chains in these molecular species ofAFP have not been
fully determined.
In this manuscript, we report the chemical structures of
sugar chains of human AFP molecular species with special
reference to reactivity to lectins and the disease category.
Materials and methods
Materials
AFP specimens were prepared from serum samples of two
patients with HCC and a patient with gallbladder carcinoma
which metastasises to the liver by affinity chromatography as
described previously (Aoyagi et al., 1977). Con A- and LCA-
Sepharose 4B beads were obtained from Pharmacia Fine
Chemicals, Uppsala, Sweden. Lyophilised Con A and LCA,
bovine epididymal a-L-fucosidase, Jack beans P-N-acetyl-
glucosaminidase, and neuraminidase from Clostridium per-
fringens, type X, were from Sigma Chemical Co., St. Louis,
MO, USA. P-Galactosidase from E. coli was purchased from
Boehringer Mannheim, Germany. Authentic pyridylamino
(PA)-oligosaccharide standards were from Takara Shuzo Co.,
Ltd. Kyoto, Japan, and their structures were verified by
'H-nuclear magnetic resonance by the manufacturer. An-
hydrous hydrazine was from Pierce Chemical Company,
Rockford, Ill, USA and 2-aminopyridine was from Nacalai
Tesque, Kyoto, Japan. Sodium cyanoborohydride was from
Aldrich Chem. Co., Milw., WI, USA. The other reagents
were of analytical grade.
Methods
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis
The purity of the AFP prepared by affinity chromatography
was checked by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis according to the method of Laemmli (1970).
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Isolation ofAFP species with different affinityfor Con A and
LCA
Four AFP species, i.e., Con A-nonreactive and LCA-
nonreactive (Con A(-)/LCA(-)), Con A-nonreactive and
LCA-reactive (Con A(-)/LCA(+)), Con A-reactive and
LCA-nonreactive (Con A(+)/LCA(-)), Con A-reactive and
LCA-reactive (Con A(+)/LCA(+)} species were obtained
from each AFP sample with Con A- and LCA-Sepharose 4B
as described previously (Aoyagi et al., 1985).
Crossed immunoaffinoelectrophoresis
Purity of each molecular species of AFP with different
affinity for Con A and LCA was examined by crossed
immunoaffinoelectrophoresis as described previously (Aoyagi
et al., 1984).
Preparation ofPA-sugar chains
Sugar chains of AFP samples were released by hydrazinolysis
at 100°C for 10 h and free amino groups were N-acetylated.
Then, the free oligosaccharides were reductively aminated
with a fluorescent reagent, 2-aminopyridine, by use of
sodium cyanoborohydride, and PA-derivatives of each oligo-
saccharide preparation were fractionated by Sephadex G-15
gel filtration (1 x 50cm) according to the method described
previously (Hase et al., 1984; Yamamoto et al., 1989).
Glycosidase digestion ofPA-sugar chains
Digestion with neuraminidase was performed in 0.1 M
sodium acetate buffer, pH 5.0; with a-fucosidase in 0.1 M
sodium citrate buffer, pH 6.0; and with P-galactosidase and
P-N-acetylglucosaminidase in 0.01 M sodium phosphate buffer,
pH 7.0, containing 1 mM MgCl2. All digestions were done
with 50-100 pmoles ofeach PA-sugar chain at 37°C for 20 h,
and reactions were stopped by heating the solution at 100°C
for 2 min.
High-performance liquid chromatography (HPLC)
The separation of PA-oligosaccharides was carried out by
HPLC using a Hitachi 655A chromatograph equipped with a
Rheodyne Model 7125 injector and a Hitachi Model F-1050
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kD
67
Figure 1 Sodium dodecyl sulfate polyacrylamide gel electro-
phoretic patterns of AFP from patients with HCC-1 a, HCC-2 b,
and gallbladder carcinoma which metastasises to the liver c. d,
Molecular weight marker.
Table I Relative yields(%) of four AFP species separated by lectin
affinity chromatography with Con A and LCA
HCC-1 HCC-2 Gallbladder
AFP species (patient 1) (patient 2) carcinoma
Con A(+)/LCA(+) 52 51 43
Con A(+)/LCA(-) 39 41 10
Con A(-)/LCA(+) 5 4 39
Con A(-)/LCA(-) 4 4 8
a(+) and (-) represent 'reactive' and 'nonreactive', respectively.
fluorescence spectrophotometer with reversed-phase HPLC
(Cosmosil 5C18-P, 0.46 x 15 cm, Nacalai Tesque) and size-
fractionation HPLC (TSK-GEL Amide-80, 0.46 x 25 cm,
Tosoh Corp.) essentially according to the methods ofTomiya
et al. (1988) and Yamamoto et al. (1989). In both HPLC
systems, PA-oligosaccharides were detected by fluorescence
using excitation and emission wavelengths of 320 and 400
nm, respectively.
Results
Preparation offour AFP species different in lectin affinity
Purity of each patient AFP sample was established by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis as
shown in Figure 1. The yield of AFP purification by affinity
chromatography from each patient was about 90%, and the
relative yields of four AFP species separated by lectin affinity
chromatography with two lectin columns are listed in Table
I. Purity and affinity for two lectins of each species were
confirmed by crossed immunoaffinoelectrophoresis (results
not shown).
Each of these four AFP species (30-100 nmoles) different
in lectin affinity was subjected to hydrazinolysis to prepare
PA-oligosaccharides, and subsequently PA-sugar chains from
each species (50-300 pmoles) were applied to HPLC ana-
lysis. The yields of hydrazinolysis and reductive amination
with 2-aminopyridine were 60-70 and 85-90%, respectively.
Thus, overall yield was around 60%.
Carbohydrate structure ofCon A(+)/LCA(-) species ofAFP
The PA-oligosaccharide of the Con A(+)/LCA(-) species of
AFP from HCC patient 1 was eluated at the position of the
authentic PA-biantennary chain', both on reversed-phase
HPLC (Figure 2) and on size-fractionation HPLC. by ,-galac-
tosidase and subsequent P-N-acetylglucosaminidase digestion,
the elution positions were converted to that of the PA-
agalactobiantennary chain, and that of the PA-trimannosyl
sugar chain, respectively (results not shown). Essentially iden-
tical elution profiles of HPLC were obtained with the PA-
oligosaccharide of the Con A(+)/LCA(-) species of AFP
from HCC patient 2 and the patient with gallbladder car-
cinoma which metastasises to the liver (results not shown).
Carbohydrate structure ofCon A(+)/LCA(+) species ofAFP
The PA-oligosaccharide of the Con A(+)/LCA(+) species of
AFP from HCC patient 1 was eluted at the position of the
authentic PA-fucosylated biantennary chain, both on revers-
ed-phase HPLC (Figure 3a) and on size-fractionation HPLC
(Figure 4a). Upon digestion with fucosidase, the elution posi-
tion was converted to that of the authentic PA-biantennary
chain, as shown in Figure 3c (reversed-phase HPLC) and
Figure 4c (size-fractionation HPLC). Essentially identical
results were obtained for the PA-oligosaccharides of the Con
A(+)/LCA(+) species of AFP from HCC patient 2 and the
patient with gallbladder carcinoma which metatasises to the
liver (results not shown).a1) 0
0
en
a)
0 0
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Figure 2 Reversed-phase HPLC elution profile of a PA-oligosaccharide from the Con A(+)/LCA(-) species of AFP of HCC
patient 1. The PA-oligosaccharide (1 in a) was eluted at the same position as that of the authentic PA-biantennary chain (1 in b).
Carbohydrate structure ofCon A(-)/LCA(+) species ofAFP
Figure 5a shows a reversed-phase HPLC elution pattern of
the PA-oligosaccharide of the Con A(-)/LCA(+) species of
AFP from HCC patient 1. The elution position was same as
that of the authentic PA-fucosylated and N-acetylglucos-
aminylated biantennary chain. The elution position of
Amide-80 size-fractionation HPLC was also same as that of
the reference compound mentioned above (results not
shown). Fucosidase digestion converted the elution position
on reversed-phase HPLC of this PA-oligosaccharide to that
c
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of the PA-N-acetylglucosaminylated biantennary chain as
shown in Figure 5b. Essentially identical results were
obtained for the Con A(-)/LCA(+) species of AFP from
HCC patient 2 and the patient with gallbladder carcinoma
which metastasises to the liver (results not shown).
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Figure 3 Reversed-phase HPLC elution profiles of native and
fucosidase-digested PA-oligosaccharides from the Con A( +)/
LCA(+) species of AFP of HCC patient 1. The native PA-
oligosaccharide (1 in a) was eluted at the same position as that of
the PA-fucosylated biantennary chain (1 in b). After fucosidase-
digestion this PA-oligosaccharide gave a new major peak (2 in c)
eluted at the position of the PA-biantennary chain (2 in d).
0 10 20 30
Elution time (min)
Figure 4 Size-fractionation HPLC elution profiles of native and
fucosidase-digested PA-oligosaccharides from the Con A( +)/
LCA(+) species of AFP of HCC of patient 1. The PA-oligosac-
charide (1 in a) was eluted at the position of the PA-fucosylated
biantennary chain (1 in b). The fucosidase-digested PA-oligo-
saccharide of the Con A(+)/LCA(+) species of AFP (2 in c) was
eluted at the position of the PA-biantennary chain (2 in d).
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Figure 5 Reversed-phase HPLC elution profiles of native and
fucosidase-digested PA-oligosacchandes from the Con A(-)/
LCA(+) species of AFP of HCC patient 1. The native PA-
oligosaccharide (1 in a) was eluted at the position of the PA-
fucosylated and N-acetylglucosaminylated biantennary chain (4
in c). Fucosidase-digestion gave a peak (2 in b) at the position of
the N-acetylglucosaminylated biantennary chain (peak 3 in c).
Authentic PA-oligosaccharide standards in c are: 1, biantennary
chain; 2, fucosylated biantennary chain; 3, N-acetylglucosaminy-
lated biantennary chain; and 4, fucosylated and N-acetylglucos-
aminylated chain.
Carbohydrate structure ofCon A (- )/LCA(-) species ofAFP
Figure 6a shows an elution profile of the PA-oligosaccharides
of the Con A(-)/LCA(-) species of AFP from HCC patient
1 on size-fractionation HPLC. The major peak (peak 1 in
Figure 6a), representing 40 and 45% of the total peak areas
in patient 1 and patient 2, respectively, was eluted at the
position of the authentic PA-fucosylated triantennary chain
(peak 4 in Figure 6c). The PA-triantennary oligosaccharide
(peak 3 in Figure 6c) was also detected as a minor compon-
ent (representing 14 and 22% of the total peak areas in the
respective patient, peak 2 in Figure 5a). Upon fucosidase
digestion, the major peak disappears, and an increase of the
peak at the position of the authentic PA-triantennary chain,
was observed (peak 2 in Figure 6b).
To confirm the chemical structure of the sugar chain, the
main peak oligosaccharide was collected, and a portion was
subjected to fucosidase digstion. Figure 7a shows an elution
profile of the PA-oligosaccharide thus isolated on size-
fractionation HPLC. The elution position (peak 1 in Figure
7a) was same as that of the PA-fucosylated triantennary
chain (peak 6 in Figure 7c). Fucosidase digestion gave an
oligosaccharide eluted at a position (peak 2 in Figure 7b) of
the authentic PA-triantennary chain (peak 5 in Figure 7c).
the fucosidase-treated oligosaccharide was collected and then
subjected to P-galactosidase digestion and subsequently to
P-N-acetylglucosaminidase digestion. The elution positions of
resultant oligosaccharides (peak 3 in Figure 7d and peak 4 in
Figure 7e) were identical with those of authentic oligosac-
charides, a PA-agalactotriantennary chain (peak 2 in Figure
7f), and a PA-trimannosyl chain (peak 1 in Figure 7f) stan-
dards, respectively.
The elution profile of the PA-oligosaccharide of the Con
A(-)/LCA(-) species of AFP from HCC patient 1 by
reversed-phase HPLC is shown in Figure 8. By this reversed-
phase HPLC with Cosmosil 5C18-P, the PA-oligosaccharide
of the N-acetylglucosaminylated biantennary chain and that
of the fucosylated triantennary chain were eluted at almost
the same position (peak 4 in Figure 8c and peak 5 in Figure
8d), and therefore it was difficult to know their presence or
absence. However, when digested with fucosidase, a major
peak (2 in Figure 8b) was shifted to the position of the
PA-triantennary chain (peak 3 in Figure 8c). A minor peak
(1 in Figure 8b) remaining at the initial position after re-
peated fucosidase digestions was considered to represent N-
acetylglucosaminylated biantennary chain (peak 5 in Figure
8d). These results indicated that major components of PA-
oligosaccharides of Con A(-)/LCA(-) species of AFP from
the patient with HCC was the fucosylated triantennary chain.
Although it was difficult to identify each peak, several minor
components eluted at faster positions than that of the major
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Figure 6 Size-fractionation HPLC elution profiles of native and
fucosidase-digested PA-oligosaccharides of the Con A(-)/
LCA(-) species of AFP of patient 1. The major peak (I in a,
40% of the total peak area) was eluted at the position of the
fucosylated triantennary chain (4 in c). The PA-triantennary
chain was also detected as a minor component (2 in a, 14% of
the total peak area). By fucosidase digestion, the main peak at
the elution position of the PA-fucosylated triantennary chain
disappeared, and an increase of a peak (2 in b) at the position of
PA-triantennary chain was observed. Authentic PA-oligosacchar-
ide standards in c are: 1, biantennary chain; 2, fucosylated
biantennary chain; 3, triantennary chain; and 4, fucosylated tri-
anternnary chain.
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Figure 7 Size-fractionation HPLC elution profiles of the isolated PA-oligosaccharide (peak I in Figure Sa) and its stepwise
exoglycosidase digest. The elution position of the native one (1 in a) was same as that of the fucosylated triantennary chain (6 in c),
and a-fucosidase digestion gave a peak (2 in b) corresponding to the triantennary chain (5 in b). The oligosaccharide of this peak
was collected and subjected to P-galactosidase digestion and subsequently to P-N-actylglucosaminidase digestion. The P-galac-
tosidase digest gave a peak (3 in d) corresponding to the agalactotriantennary chain (2 in f), and P-N-acetyl-glucosaminidase digest
gave a peak (4 in e) at the position of the trimannosyl chain (1 in f). Authentic PA-oligosaccharide standards in c and f are: 1,
trimannosyl chain; 2, agalactotriantennary chain; 3, biantennary chain; 4, fucosylated biantennary chain; 5, triantennary chain; and
6, fucosylated triantennary chain.
component (Figure 6a), apepared to be fucosylated species,
because after fucosidase digestion these minor peaks disap-
peared and new peaks became detectable at faster position
than that of untreated minor components (Figure 6b).
Essentially the same elution profiles on HPLC were obtain-
ed for Con A(-)/LCA(-) species ofAFP from HCC patient
2 and the patient with gallbladder carcinoma which metas-
tasises to the liver. However, the ratio (10.1) of the fuco-
sylated to non-fucosylated triantennary sugar chains of AFP
from the patient with gallbladder carcinoma which metasta-
sises to the liver was much higher than those (3.2 for patient
1 and 1.9 for patient 2) in patients with HCC. The peak
areas due to the fucosylated and the nonfucosylated trianten-
nary chains in this disease represented 32 and 3% ofthe total
area, respectively.
Discussion
It is now accepted that there are several molecular species of
AFP with different affinity for Con A and LCA. LCA binds
specifically the biantennary chain with a fucose residue at the
innermost N-acetylglucosamine residue at the trimannosyl
core (fucosylated biantennary chain) and that both with a
fucose and a bistecting-N-acetylglucosamine residue (fuco-
sylated and N-acetylglucosaminylated biantennary chain)
(Kornfeld et al., 1981). However, if these biantennary struc-
tures undergo modification of further branching leading to
triantennary structures, they become nonreactive with LCA
(Montreuil et al., 1983). On the other hand, Con A binds
specifically the biantennary and the fucosylated biantennary
chains. This binding does not occur if the biantennary sugar
chain structure undergoes modification of bisecting-glucos-
aminylation and/or further branching leading to the forma-
tion of the triantennary and tetraantennary structures
(Baenziger & Fiete, 1979).
On the basis of these facts, we have proposed the carbo-
hydrate structures of various AFP species with difference in
affinity for Con A and LCA (Aoyagi et al., 1985, 1991;
Kornfeld et al., 1981; Montreuil et al., 1983; Baenziger et al.,
1979), but they remain to be confirmed.
Recently, a very sensitive and convenient method has been
developed to study the fine carbohydrate structures by com-
bination of derivatisation into fluorescent oligosaccharide
and separation by HPLC (Hase et al., 1984; Tomiya et al.,
1988; Yamamoto et al., 1989; Nishiura et al., 1990). Since a
number of PA-oligosaccharide, the structures of which have
been established by 'H-nuclear magnetic resonance, have
become commercially available, we applied this method to
study the fine structures of various AFP species.
The present results are summarised in Table II. Here, we
propose the classification of carbohydrate structures of
human AFP according to the reactivity with lectins and the
disease category (Table II). The first is the Con A(+)/
LCA(-) sugar chain, and the structure is of the biantennary
complex type, a basic carbohydrate structure of AFP. This
structure is predominantly observed in AFP of nonneoplastic
liver diseases. The second is the Con A(+)/LCA(+) chain
composed of the fucosylated biantennary complex type,
which is predominantly observed in AFP of HCC. The third
is the Con A(-)/LCA(+) chain which is the biantennary
complex type with fucosylation and bisecting-N-acetylglucos-
aminylation, and this type is observed predominantly in AFP
of carcinomas of digestive organs which metastasise to the
liver and yolk sac tumour. The fourth is the Con A(-)/
LCA(-) chain which includes three kinds of carbohydrate
structure, namely, the biantennary complex type with bisect-
ing-acetylglucosaminylation, the triantennary complex type
and the triantennary complex type with fucosylation. TheTRIANTENNARY GLYCANS IN HUMAN oa-FETOPROTEIN 491
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Figure 8 Reversed-phase HPLC elution profiles of native a, and
fucosidase-digested PA-oligosaccharides b, from the Con A(-)/
LCA(-) species of AFP of HCC patient 1. The native oligosac-
charides gave a major peak (1 in a) at the position of the
authentic fucosylated triantennary chain (4 in c). In this system,
the N-acetylglucosaminylated biantennary chain (5 in d) was also
eluted at the same position. Fucosidase digestion resulted in an
increase of a peak (2 in b) at the position of triantennary chain (3
in c). A residual minor peak at the initial position (peak 1 in b)
was considered to the N-acetylglucosaminylated biantennary
chain (5 in d). Authentic PA-oligosaccharides in c and d are: 1,
biantennary chain; 2, fucosylated biantennary chain; 3, trianten-
nary chain; 4, fucosylated triantennary chain; 5, N-acetylglucos-
aminylated biantennary chain; and 6, fucosylated and N-acetyl-
glucosaminylated biantennary chain.
N-acetyl-glucosaminylated biantennary chain is predomin-
antly observed in AFP of carcinoma which metastasises to
the liver and yolk sac tumour. The triantennary chain and its
fucosylated form are present in AFP of HCC, carcinoma
which metastasises to the liver and yolk sac tumour.
Recently we reported that the measurement of a fucosyla-
tion index of AFP is useful for distinction between HCC and
nonneoplastic diseases of the liver (Aoyagi et al., 1984, 1991).
The fucosylation index of AFP was defined as the percentage
of the LCA-reactive species in total AFP (Aoyagi et al.,
1991). The present study revealed that more than the 40% of
Con A-nonreactive species of AFP were fucosylated, even if
it is not reactive with LCA. In our previous study the
percentage of the Con A-nonreactive species of AFP was
5 ± 7% in 351 patients with HCC (Aoyagi et al., 1991) and
we may expect a little effect of this species on the fucosyla-
tion index. Special consideration, however, should be given
to evaluate the fucosylation index determined by crossed
immunoaffinoelectrophoresis with Con A and LCA, when the
percentage of the Con A nonreactive species is high.
Thus, evidence presented here and our previous study
indicate that increases in fucosylation and in branching to
form new antennae are observed in carbohydrate chains of
AFP from patients with neoplastic diseases ofthe liver. Other
studies also indicated the tumour associated increase in fuco-
sylation and branching. For example, Campion et al. (1989)
reported the presence of fucosylated triantennary, tetraanten-
nary and pentaantennary glycans, in transferrin synthesised
by the human hepatocarcinoma cell line Hep G2. Dennis et
al. (1987, 1989) reported that transfection of an activated ras
gene into the non-metastatic line of SPI mouse mammary
tumour cells resulted in the induction of both metastatic
potential and elevated levels of P 1-6 branched oligosac-
charides and that oncogenes conferring metastatic potential
induced increased branching of asparagine-linked oligosac-
charides in rat2 fibroblasts. However, the biological signi-
ficance of this tumour-associated change remains to be clari-
fied.
Some of chemical structures of sugar chains of human
AFP have already been reported by Yoshima et al. (1980)
and Yamashita et al. (1983). However, carbohydrate struc-
tures in the molecular species of human AFP with different
affinity for Con A and LCA were not fully investigated.
These authors presented the chemical structures of sugar
chains of human AFP from ascites fluids as biantennary,
fucosylated biantennary, N-acetylglucosaminylated bianten-
nary and fucosylated, N-acetylglucoaminylated chains. These
structures were confirmed to be present in our AFP prepara-
tions.
On the other hand, they reported that human AFP did not
contain the triantennary chain. However, our present study
clearly indicated the presence of the triantennary chains with
and without a fucose residue at the innermost N-acetyl-
glucosamine residue in AFP from patients with neoplastic
diseases of the liver. Thus, this is the first report to establish
the presence of these structures in detail in human AFP.
Table II Classification ofcarbohydrate structures ofAFPand their reactivity to lectins with
special reference to disease category
Lectin reactivity" Carbohydrate structure Disease categoryb
Con A(+)/LCA(-) Biantennary sugar chain Non-neoplastic liver diseases
Con A(+)/LCA(+) Fucosylated biantennary sugar Hepatocellular carcinoma
chain
Con A(-)/LCA(+) Fucosylated and N-acetyl- Carcinomas ofdigestive
glucosaminylated biantennary organs which metastasise to
sugar chain the liver and yolk sac tumour
Con A(-)/LCA(-) N-Acetylglucosaminylated Carcinomas of digestive
biantennary sugar chain organs which metastasise to
the liver and yolk sac tumour
Triantennary and fucosylated Hepatocellular carcinoma,
triantennary sugar chains carcinomas of digestive organs
which metastasise to the liver
and yolk sac tumour
'(+) and (-) represent 'reactive' and 'nonreactive', respectively. bDisease in which AFP
with the relevant carbohydrate structure is found characteristically.
a
b492 Y. AOYAGI et al.
In the case of AFP of foetal calf serum, Krusius and
Ruoslahti (1982) found the same structure at the triantennary
chain reported here. Bayard et al. (1983) showed that the
presence in rat AFP of a similar species to our N-acetyl-
glucosaminylated biantennary chain. Although the precise
molecular basis for these variations is not clear at present, it
is conceivable to assume that the difference in a set of sugar
transferases expressed would lead to the qualitative and
quantitative differences in each molecular species of AFP.
This study was supported in part by a Grant-in-Aid from The
Niigata University Science Foundation.
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